3-iodobenzylguanidine has been researched along with Cognition Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, K; Kawasaki, R; Oda, H; Ohkawa, S; Shimada, K; Terashima, A; Yamane, Y | 1 |
| Fujishiro, H; Kosaka, K; Ozaki, N; Ukai, K; Watanabe, M | 1 |
| Choi, HS; Jung, YA; Kim, JS; Lee, KS; Lee, PH; Oh, YS; Park, HE; Park, IS; Ryu, DW; Song, IU; Yoo, IR | 1 |
| Camacho, V; Carrio, I; Estorch, M; Flotats, A; Kulisevsky, J; Paredes, P; Rivera, E; Rodríguez-Revuelto, A | 1 |
| Akiyama, N; Kobayashi, K; Koshino, Y; Nakano, H; Sumiya, H; Urata, K | 1 |
| Artigas, C; Camacho, V; Carrió, I; Deportos, J; Domènech, A; Duch, J; Estorch, M; Fernández, A; Flotats, A; Geraldo, LL; Lleó, A; Marquié, M | 1 |
6 other study(ies) available for 3-iodobenzylguanidine and Cognition Disorders
| Article | Year |
|---|---|
Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Cognition Disorders; Female; Humans; Inosine Monophosphate; Lewy Body Disease; Magnetic Resonance Imaging; Male; Mental Status Schedule; Myocardial Perfusion Imaging; Neuropsychological Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Similarity of symptoms between transient epileptic amnesia and Lewy body disease.
Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Anticonvulsants; Cognition Disorders; Electroencephalography; Female; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Myocardial Perfusion Imaging; Parkinsonian Disorders; Piracetam; Seizures; Tomography, Emission-Computed, Single-Photon | 2017 |
Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?
Topics: 3-Iodobenzylguanidine; Aged; Cognition Disorders; Constipation; Cost of Illness; Female; Heart; Humans; Hypotension, Orthostatic; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2017 |
Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Cognition Disorders; Diagnosis, Differential; Early Diagnosis; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Neurodegenerative Diseases; Reproducibility of Results; Time Factors | 2008 |
Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Aged, 80 and over; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Psychotic Disorders; Radiopharmaceuticals | 2010 |
[Utility of early imaging of myocardial innervation scintigraphy in the diagnosis of Lewy Body Dementia].
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Imaging Techniques; Cognition Disorders; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Neurodegenerative Diseases; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2013 |